BeStock  
Stocks › Biotechnology › MAZE

Maze Therapeutics MAZE

US equityMarket cap rank #2785Biotechnology
$31.37 −$1.06 (-3.27%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $31.37 0.00%
Open$31.77
Prev close$32.43
Day range$30.88 – $32.80
Volume818.9K
Market cap$1.72B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-12.8x
CheapRich

Around its usual level · 44th percentile, 5-year average 20.4x

Price / book4.4x
CheapRich

Above its usual level · 67th percentile, 5-year average 3.1x

#4242 of 5328 stocks by PB (1 = cheapest)

Price / sales93.9x
CheapRich

Around its usual level · 58th percentile, 5-year average 288.8x

#4941 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-78x36x150x264xJan '25Dec '25Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$44.26
Price vs. fair value-29.1%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 4.38 – 3.07 67% (pricier than usual) #4242 of 5328 (1 = cheapest)
PE -12.80 -9.00 20.42 44% (cheaper than usual) –
PS 93.86 277.43 288.78 58% (pricier than usual) #4941 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on MAZE.

Sign in to join the discussion.

Scroll to Top